Summary & Overview
HCPCS Level II C2615: Pulmonary Sealant, Liquid
HCPCS Level II code C2615 identifies a liquid pulmonary sealant product used during pulmonary procedures to achieve tissue sealing. This code matters nationally because device and supply codes influence coverage, billing consistency, and hospital procedural cost accounting for thoracic and interventional pulmonology services. Clarity on coding supports accurate claims submission, inventory management, and potential payment determinations for facilities performing lung sealant procedures.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, the clinical and procedural context where the sealant is used, and the typical site of service. The publication also outlines common modifiers associated with supply and device claims (listed in the input) and indicates where additional coding details such as related taxonomies, ICD-10 diagnoses, and service-line mappings are not provided in the source data.
This summary provides operational context for billing teams, clinical coders, and revenue managers seeking a national-level understanding of HCPCS Level II code C2615, including where to expect its use in clinical workflows and the payer landscape relevant to claims processing.
Billing Code Overview
HCPCS Level II code C2615 denotes sealant, pulmonary, liquid, a product or supply used to create a seal within the pulmonary system. The service type is device/supply for pulmonary sealing procedures, and the typical site of service is hospital operating room or procedural areas where pulmonary interventions are performed, including interventional pulmonology suites and thoracic surgery settings.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with persistent or recurrent air leak after pulmonary resection or following bronchopleural fistula is admitted to the thoracic surgery service. The surgical team evaluates the air leak via chest tube drainage and bedside bronchoscopy. After conservative measures fail, the team performs a bronchoscopic instillation of a liquid pulmonary sealant (C2615) to seal the fistula or alveolar-pleural leak. The procedure is performed in an operating room or bronchoscopy suite with conscious sedation or general anesthesia depending on patient stability. Pre-procedure workflow includes imaging review (chest radiograph or CT), coagulation assessment, informed consent, and documentation of indications and expected outcomes. During the procedure the bronchoscopist directs a catheter to the leak site and applies the Sealant, pulmonary, liquid under direct visualization. Post-procedure care includes chest tube monitoring, serial chest imaging, pain control, and recording of any complications. Discharge planning addresses follow-up imaging and possible removal of chest drains once the leak resolves.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work or resources required for the sealant instillation are substantially greater than typical (document rationale). |